What did The a2 Milk Company Limited announce?
The a2 Milk Company Limited (NZX: ATM) filed “Disclosure of relevant interests” with NZX on 26 August 2026, as an insider/shareholder notice announcement.
- Which company?
- The a2 Milk Company Limited (NZX: ATM)
- When was it filed?
- 26 August 2026
- Where is the original?
- NZX announcement
Disclosure of relevant interests
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
The a2 Milk Company Limited (ATM)
Date this disclosure made:
27-Aug-2026
Date of last disclosure: 03-Dec-2025
Director or senior manager giving disclosure
Full name(s):Amanda Hart
Name of listed issuer:
The a2 Milk Company Limited
Name of related body corporate (if applicable):N/A
Position held in listed issuer:Chief People and Culture Officer
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products: (1) Unlisted performance rights
(Performance Rights) representing
an entitlement to acquire fully paid
ordinary shares in ATM (Ordinary
Shares).
(2) Ordinary Shares.
Nature of the affected relevant interest(s):Registered holder and beneficial
owner.
For that relevant interest-
Number held in class before acquisition or disposal:(1) 184,320 performance rights of
which:
(a) 80,271 are due to vest on a
date to be determined by the Board
following the release of ATM’s full year
audited results for FY2026 provided
certain performance conditions are
met;
(b) 64,947 are due to vest on a
date to be determined by the Board
following the release of ATM's full year
audited results for FY2027 provided
certain performance conditions are
met; and
(c) 39,102 are due to vest on a
date to be determined by the Board
following release of ATM's full year
audited results for FY2028 provided
certain performance conditions are
met.
(2) 52,579 Ordinary Shares.
Number held in class after acquisition or disposal:
(1) 104,049 performance rights of
which:
(a) 64,947 are due to vest on a
date to be determined by the Board
following the release of ATM's full year
audited results for FY2027 provided
certain performance conditions are
met; and
(b) 39,102 are due to vest on a
date to be determined by the Board
following release of ATM's full year
audited results for FY2028 provided
certain performance conditions are
met.
(2) 132,850 Ordinary Shares.
Current registered holder(s):(1)(a) and (2) Amanda Hart.
(1)(b) & (c) Lac Deamer Hart Pty Ltd.
Registered holder(s) once transfers are registered:(1)(a) & (b) Lac Deamer Hart Pty Ltd.
(2) Amanda Hart.
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative: N/A
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:
1
Details of transactions requiring disclosure-
Date of transaction:
20-Aug-2026
Nature of transaction: Vesting and automatic exercise of
80,271 Performance Rights, resulting
in the transfer of 80,271 Ordinary
Shares to Amanda Hart.
Name of any other party or parties to the transaction (if known):
a2 ESS Holdings Pty Limited as
trustee for a2 Group Employee Share
Trust (transferor of Ordinary Shares)
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
Nil
Number of financial products to which the transaction related:
(1) 80,271 Peformance Rights
(2) 80,271 Ordinary Shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
N/A
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
18 August 2026
---
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
The a2 Milk Company Limited (ATM)
Date this disclosure made:
27-Aug-2026
Date of last disclosure:
06-Nov-2025
Director or senior manager giving disclosure
Full name(s):
Ping (Chopin) Zhang
Name of listed issuer:
The a2 Milk Company Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Chief Supply Chain Officer
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products: (1) Unlisted performance rights
(Performance Rights) representing an
entitlement to acquire fully paid ordinary
shares (Ordinary Shares) in ATM.
(2) Ordinary Shares.
Nature of the affected relevant interest(s):
Registered holder and beneficial owner.
For that relevant interest-
Number held in class before acquisition or disposal:(1) 260,231 Performance Rights of
which:
(a) 113,157 are due to vest on a
date to be determined by the Board
following the release of ATM’s full year
audited results for FY2026 provided
certain performance conditions are met;
(b) 92,460 are due to vest on a date
to be determined by the Board following
the release of ATM’s full year audited
results for FY2027 provided certain
performance conditions are met; and
(c) 54,614 are due to vest on a date
to be determined by the Board following
the release of ATM's full year audited
results for FY2028 provided certain
performance conditions are met.
(2) 23,555 Ordinary Shares.
Number held in class after acquisition or disposal:(1) 147,074 Performance Rights of
which:
(a) 92,460 are due to vest on a date
to be determined by the Board following
the release of ATM’s full year audited
results for FY2027 provided certain
performance conditions are met; and
(b) 54,614 are due to vest on a date
to be determined by the Board following
the release of ATM's full year audited
results for FY2028 provided certain
performance conditions are met.
(2) 136,712 Ordinary Shares.
Current registered holder(s):
Ping Zhang
Registered holder(s) once transfers are registered:
Ping Zhang
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:
1
Details of transactions requiring disclosure-
Date of transaction:
20-Aug-2026
Nature of transaction: Vesting and automatic exercise of
113,157 Performance Rights, resulting
in the transfer of 113,157 Ordinary
Shares to Ping Zhang.
Name of any other party or parties to the transaction (if known):
a2 ESS Holdings Pty Limited as trustee
for a2 Group Employee Share Trust
(transferor of Ordinary Shares)
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
Nil
Number of financial products to which the transaction related:
(a) 113,157 Performance Rights
(b) 113,157 Ordinary Shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
N/A
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
19 August 2026
---
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
The a2 Milk Company Limited (ATM)
Date this disclosure made:
27-Aug-2026
Date of last disclosure:
02-Mar-2026
Director or senior manager giving disclosure
Full name(s):
David Landt Bortolussi
Name of listed issuer:
The a2 Milk Company Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Managing Director and Chief
Executive Officer
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
(1) Unlisted performance rights (Performance Rights)
representing an entitlement to acquire fully paid ordinary
shares in ATM (Ordinary Shares).
(2) Ordinary Shares.
Nature of the affected relevant interest(s):Beneficial owner
For that relevant interest-
Number held in class before acquisition or disposal:(1) 1,553,008 Performance Rights of which:
(a) 690,066 are due to vest on a date to be determined by the
Board following the release of ATM’s full year audited results
for FY2026 provided certain performance conditions are met;
(b) 538,336 are due to vest on a date to be determined by the
Board following the release of ATM’s full year audited results
for FY2027 provided certain performance conditions are met;
and
(c) 324,606 are due to vest on a date to be determined by the
Board following the release of ATM’s full year audited results
for FY2028 provided certain performance conditions are met.
(2) 882,729 Ordinary Shares.
Number held in class after acquisition or disposal:(1) 862,942 Performance Rights of which:
(a) 538,336 are due to vest on a date to be determined by the
Board following the release of ATM’s full year audited results
for FY2027 provided certain performance conditions are met;
and
(b) 324,606 are due to vest on a date to be determined by the
Board following the release of ATM’s full year audited results
for FY2028 provided certain performance conditions are met
(2) 1,572,795 Ordinary Shares
Current registered holder(s):1)(a) & (b) DMZSK Super Pty Ltd <D&M
Bortolussi Superannuation Fund A/c>
(1)(c) DMZSK Pty Ltd <D&M Bortolussi
Family Trust A/c>
(2) DMZSK Pty Ltd <D&M Bortolussi Family Trust A/c> which
is the registered holder of 640,383 Ordinary Shares, and
DMZSK Super Pty Ltd <D&M Bortolussi Superannuation Fund
A/c> which is the registered holder of 242,346 Ordinary
Shares
Registered holder(s) once transfers are registered:1)(a) DMZSK Super Pty Ltd <D&M
Bortolussi Superannuation Fund A/c>
(1)(b) DMZSK Pty Ltd <D&M Bortolussi
Family Trust A/c>
(2) DMZSK Pty Ltd <D&M Bortolussi Family Trust A/c> which
is the registered holder of 640,383 Ordinary Shares, and
DMZSK Super Pty Ltd <D&M Bortolussi Superannuation Fund
A/c> which is the registered holder of 932,412 Ordinary
Shares
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:
1
Details of transactions requiring disclosure-
Date of transaction:
20-Aug-2026
Nature of transaction:
Vesting and automatic exercise of 690,066 Performance
Rights, resulting in the transfer of 690,066 Ordinary Shares to
DMZSK Super Pty Ltd <D&M Bortolussi Superannuation Fund
A/c>.
Name of any other party or parties to the transaction (if known):
a2 ESS Holdings Pty Limited as trustee for a2 Group
Employee Share Trust (transferor of Ordinary Shares).
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
Nil
Number of financial products to which the transaction related: (1) 690,066 Peformance Rights
(2) 690,066 Ordinary Shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
N/A
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
18 August 2026
---
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
The a2 Milk Company Limited (ATM)
Date this disclosure made:
27-Aug-2026
Date of last disclosure:
06-Nov-2025
Director or senior manager giving disclosure
Full name(s):
David Muscat
Name of listed issuer:
The a2 Milk Company Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Chief Financial Officer
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
(1) Unlisted performance rights (Performance
Rights) representing an entitlement to acquire
fully paid ordinary shares (Ordinary Shares) in
ATM.
(2) Ordinary Shares
Nature of the affected relevant interest(s):
Registered holder and beneficial owner.
For that relevant interest-
Number held in class before acquisition or disposal:
1) 404,416 Performance Rights of which:
(a) 172,605 are due to vest on a date to be
determined by the Board following the release
of ATM’s full year audited results for FY2026
provided certain performance conditions are
met;
(b) 144,652 are due to vest on a date to be
determined by the Board following the release
of ATM’s full year audited results for FY2027
provided certain performance conditions are
met; and
(c) 87,159 are due to vest on a date to be
determined by the Board following the release
of ATM’s full year audited results for FY2028
provided certain performance conditions are
met.
(2) 63,107 Ordinary Shares
Number held in class after acquisition or disposal:
1) 231,811 Performance Rights of which:
(a) 144,652 are due to vest on a date to be
determined by the Board following the release
of ATM’s full year audited results for FY2027
provided certain performance conditions are
met; and
(b) 87,159 are due to vest on a date to be
determined by the Board following the release
of ATM’s full year audited results for FY2028
provided certain performance conditions are
met.
(2) 235,712 Ordinary Shares
Current registered holder(s):
(1) (a) and (b) David Muscat
(1) (c) Kathryn Anne Muscat
(2) David Muscat
Registered holder(s) once transfers are registered:
(1) (a) David Muscat
(1) (b) Kathryn Anne Muscat
(2) David Muscat
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:
1
Details of transactions requiring disclosure-
Date of transaction:
20-Aug-2026
Nature of transaction:
Vesting and automatic exercise of 172,605
Performance Rights, resulting in the transfer of
172,605 Ordinary Shares to David Muscat.
Name of any other party or parties to the transaction (if known):
a2 ESS Holdings Pty Limited as trustee for a2
Group Employee Share Trust (transferor of
Ordinary Shares)
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
Nil
Number of financial products to which the transaction related:
(a) 172,605 Performance Rights
(b) 172,605 Ordinary Shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
N/A
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
19 August 2026
---
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
The a2 Milk Company Limited (ATM)
Date this disclosure made:
27-Aug-2026
Date of last disclosure:
03-Dec-2025
Director or senior manager giving disclosure
Full name(s):
Edith Bailey
Name of listed issuer:
The a2 Milk Company Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Chief Marketing Officer (former)
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products: (1) Unlisted performance rights
(Performance Rights) representing an
entitlement to acquire fully paid ordinary
shares in ATM (Ordinary Shares).
(2) Ordinary Shares
Nature of the affected relevant interest(s):Registered holder and beneficial owner
For that relevant interest-
Number held in class before acquisition or disposal:(1) 210,291 Performance Rights of
which:
(a) 91,598 are due to vest on a date to
be determined by the
Board following the release of ATM’s full
year audited results for
FY2026 provided certain performance
conditions are met;
(b) 74,081 are due to vest on a date to
be determined by the
Board following the release of ATM’s full
year audited results for
FY2027 provided certain performance
conditions are met; and
(c) 44,612 are due to vest on a date to
be determined by the
Board following the release of ATM’s full
year audited results for
FY2028 provided certain performance
conditions are met.
(2) 67,049 Ordinary Shares.
Number held in class after acquisition or disposal:(1) 118,693 Performance Rights of
which:
(a) 74,081 are due to vest on a date to
be determined by the
Board following the release of ATM’s full
year audited results for
FY2027 provided certain performance
conditions are met; and
(b) 44,612 are due to vest on a date to
be determined by the
Board following the release of ATM’s full
year audited results for
FY2028 provided certain performance
conditions are met.
(2) 158,647 Ordinary Shares.
Current registered holder(s):
Edith Bailey
Registered holder(s) once transfers are registered:
Edith Bailey
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:
1
Details of transactions requiring disclosure-
Date of transaction:
20-Aug-2026
Nature of transaction: Vesting and automatic exercise of
91,598 Performance Rights, resulting in
the transfer of 91,598 Ordinary Shares
to Edith Bailey.
Name of any other party or parties to the transaction (if known):
a2 ESS Holdings Pty Limited as trustee
for a2 Group Employee Share Trust
(transferor of Ordinary Shares)
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
Nil
Number of financial products to which the transaction related:
(1) 91,598 Performance Rights
(2) 91,598 Ordinary Shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
N/A
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
19 August 2026
---
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
The a2 Milk Company Limited (ATM)
Date this disclosure made:
27-Aug-2026
Date of last disclosure:
02-Mar-2026
Director or senior manager giving disclosure
Full name(s):
Jaron James McVicar
Name of listed issuer:
The a2 Milk Company Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Managing Director - ANZ and
Sustainability
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products: (1) Unlisted performance rights
(Performance Rights) representing an
entitlement to acquire fully paid ordinary
shares in ATM (Ordinary Shares).
(2) Ordinary Shares.
Nature of the affected relevant interest(s):Spouse of registered holder and
beneficial owner.
For that relevant interest-
Number held in class before acquisition or disposal:(1) 214,230 Performance Rights of
which:
(a) 89,190 are due to vest on a date
to be determined by the Board following
the release of ATM’s full year audited
results for FY2026 provided certain
performance conditions are met; and
(b) 76,437 are due to vest on a date
to be determined by the Board following
the release of ATM’s full year audited
results for FY2027 provided certain
performance conditions are met.
(c) 48,603 are due to vest on a date
to be determined by the Board following
release of ATM's full year audited
results for FY2028 provided certain
performance conditions are met.
(2) 117,855 Ordinary Shares.
Number held in class after acquisition or disposal:(1) 125,040 Performance Rights of
which:
(a) 76,437 are due to vest on a date
to be determined by the Board following
the release of ATM’s full year audited
results for FY2027 provided certain
performance conditions are met; and
(b) 48,603 are due to vest on a date
to be determined by the Board following
release of ATM's full year audited
results for FY2028 provided certain
performance conditions are met.
(2) 207,045 Ordinary Shares.
Current registered holder(s):(1)(a),(b) & (c) Charlotte Mary McVicar.
(2) Jaron James McVicar.
Registered holder(s) once transfers are registered:(1)(a) & (b) Charlotte Mary McVicar.
(2) Jaron James McVicar holds 117,855
Ordinary Shares and Charlotte Mary
McVicar holds 89,190 Ordinary Shares.
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:
1
Details of transactions requiring disclosure-
Date of transaction:
20-Aug-2026
Nature of transaction:
Vesting and automatic exercise of
89,190 Performance Rights, resulting in
the transfer of 89,190 Ordinary Shares
to Charlotte Mary McVicar.
Name of any other party or parties to the transaction (if known):
a2 ESS Holdings Pty Limited as trustee
for a2 Group Employee Share Trust
(transferor of Ordinary Shares)
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
Nil
Number of financial products to which the transaction related:
(1) 89,190 Performance Rights
(2) 89,190 Ordinary Shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
N/A
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
19 August 2026
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
---
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
The a2 Milk Company Limited (ATM)
Date this disclosure made:
27-Aug-2026
Date of last disclosure:
09-Apr-2026
Director or senior manager giving disclosure
Full name(s):
Kate Tidbury
Name of listed issuer:
The a2 Milk Company Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Chief Legal Officer & Company Secretary
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products: (1) Unlisted performance rights
(Performance Rights) representing an
entitlement to acquire fully paid ordinary
shares in ATM (Ordinary Shares).
(2) Ordinary Shares.
Nature of the affected relevant interest(s): Registered holder and beneficial owner.
For that relevant interest-
Number held in class before acquisition or disposal:
(1) 46,042 Performance Rights of which:
(a) 19,621 are due to vest on a date to
be determined by the Board following the
release of ATM’s full year audited results
for FY2026 provided certain performance
conditions are met;
(b) 16,399 are due to vest on a date to
be determined by the Board following the
release of ATM's full year audited results
for FY2027 provided certain performance
conditions are met; and
(c) 10,022 are due to vest on a date to
be determined by the Board following
release of ATM's full year audited results
for FY2028 provided certain performance
conditions are met.
(2) 15,019 Ordinary Shares.
Number held in class after acquisition or disposal:
(1) 26,421 Performance Rights of which:
(a) 16,399 are due to vest on a date to
be determined by the Board following the
release of ATM's full year audited results
for FY2027 provided certain performance
conditions are met; and
(b) 10,022 are due to vest on a date to
be determined by the Board following
release of ATM's full year audited results
for FY2028 provided certain performance
conditions are met.
(2) 34,640 Ordinary Shares.
Current registered holder(s):Kate Tidbury
Registered holder(s) once transfers are registered:Kate Tidbury
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:
1
Details of transactions requiring disclosure-
Date of transaction:
20-Aug-2026
Nature of transaction: Vesting and automatic exercise of 19,621
Performance Rights, resulting in the
transfer of 19,621 Ordinary Shares to Kate
Tidbury.
Name of any other party or parties to the transaction (if known):
a2 ESS Holdings Pty Limited as trustee for
a2 Group Employee Share Trust (transferor
of Ordinary Shares)
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
Nil
Number of financial products to which the transaction related:
(1) 19,621 Peformance Rights
(2) 19,621 Ordinary Shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
N/A
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
19 August 2026
---
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
The a2 Milk Company Limited (ATM)
Date this disclosure made:
27-Aug-2026
Date of last disclosure:
06-Nov-2025
Director or senior manager giving disclosure
Full name(s):
Kevin Bush
Name of listed issuer:
The a2 Milk Company Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Managing Director - USA
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
(1) Unlisted performance rights
(Performance Rights) representing an
entitlement to acquire fully paid ordinary
shares in ATM (Ordinary Shares).
(2) Ordinary Shares.
Nature of the affected relevant interest(s):Spouse of registered holder and
beneficial owner.
For that relevant interest-
Number held in class before acquisition or disposal:(1) 309,023 Performance Rights of
which:
(a) 138,297 are due to vest on a
date to be determined by the Board
following the release of ATM’s full year
audited results for FY2026 provided
certain performance conditions are met;
(b) 105,531 are due to vest on a
date to be determined by the Board
following the release of ATM's full year
audited results for FY2027 provided
certain performance conditions are met;
and
(c) 65,195 are due to vest on a date
to be determined by the Board following
release of ATM's full year audited
results for FY2028 provided certain
performance conditions are met.
(2) 251,021 Ordinary Shares.
Number held in class after acquisition or disposal:(1) 170,726 Performance Rights of
which:
(a) 105,531 are due to vest on a
date to be determined by the Board
following the release of ATM's full year
audited results for FY2027 provided
certain performance conditions are met;
and
(b) 65,195 are due to vest on a date
to be determined by the Board following
release of ATM's full year audited
results for FY2028 provided certain
performance conditions are met.
(2) 349,557 Ordinary Shares.
Current registered holder(s):
(1)(a) Jennifer O'Brien <Kevin Bush
A/c>
(1)(b) & (c) Kevin Bush
(2) Jennifer O'Brien <Kevin Bush A/c>
holds 64,196 Ordinary Shares and
Kevin Bush holds 186,825 Ordinary
Shares.
Registered holder(s) once transfers are registered:
(1)(a) & (b) Kevin Bush
(2) Jennifer O'Brien <Kevin Bush A/c>
holds 162,732 Ordinary Shares and
Kevin Bush holds 186,825 Ordinary
Shares.
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:
1
Details of transactions requiring disclosure-
Date of transaction:
20-Aug-2026
Nature of transaction: Vesting and automatic exercise of
138,297 Performance Rights resulting in
the transfer of 98,536 Ordinary Shares
to Jennifer O'Brien <Kevin Bush A/c>
and retention of 39,761 Ordinary Shares
on account of US income tax, social
security and Medicare witholding
obligations.
Name of any other party or parties to the transaction (if known):
a2 ESS Holdings Pty Limited as trustee
for a2 Group Employee Share Trust
(transferor of Ordinary Shares)
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
Nil
Number of financial products to which the transaction related:
(1) 138,297 Performance Rights
(2) 98,536 Ordinary Shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
N/A
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
18 August 2026
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
---
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
The a2 Milk Company Limited (ATM)
Date this disclosure made:
27-Aug-2026
Date of last disclosure:
02-Mar-2026
Director or senior manager giving disclosure
Full name(s):
Xiao Li
Name of listed issuer:
The a2 Milk Company Limited
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Chief Executive – Greater China
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
(1) Unlisted performance rights (Performance Rights)
representing an entitlement to acquire fully paid ordinary
shares in ATM (Ordinary Shares).
(2) Ordinary Shares.
Nature of the affected relevant interest(s):(1) Registered holder and beneficial owner.
(2) Beneficial owner.
For that relevant interest-
Number held in class before acquisition or disposal:(1) 830,686 performance rights of which:
(a) 362,741 Performance Rights due to vest on a date to
be determined by the Board following the release of
ATM’s full year audited results for FY2026 provided
certain performance conditions are met;
(b) 289,377 Performance Rights due to vest on a date to
be determined by the Board following the release of
ATM’s full year audited results for FY2027 provided
certain performance conditions are met; and
(c) 178,568 Performance Rights due to vest on a date to
be determined by the Board following the release of
ATM’s full year audited results for FY2028 provided
certain performance conditions are met.
(2) 425,414 Ordinary Shares.
Number held in class after acquisition or disposal:(1) 467,945 performance rights of which:
(a) 289,377 Performance Rights due to vest on a date to
be determined by the Board following the release of
ATM’s full year audited results for FY2027 provided
certain performance conditions are met; and
(b) 178,568 Performance Rights due to vest on a date to
be determined by the Board following the release of
ATM’s full year audited results for FY2028 provided
certain performance conditions are met.
(2) 788,155 Ordinary Shares.
Current registered holder(s):
(1)(a), (b) & (c) Xiao Li
(2) Pacific Custodians Pty Limited (as custodian)
Registered holder(s) once transfers are registered:
(1)(a) & (b) Xiao Li
(2) Pacific Custodians Pty Limited (as custodian)
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
N/A
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:
1
Details of transactions requiring disclosure-
Date of transaction:
20-Aug-2026
Nature of transaction:
Vesting and automatic exercise of 362,741 Performance
Rights, resulting in the issuance of 362,741 Ordinary
Shares to Pacific Custodians Pty Limited (as custodian).
Name of any other party or parties to the transaction (if known):
a2 ESS Holdings Pty Limited as trustee for a2 Group
Employee Share Trust (transferor of Ordinary Shares)
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
Nil
Number of financial products to which the transaction related:
(1) 362,741 Performance Rights
(2) 362,741 Ordinary Shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
N/A
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
26-Aug-26
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
---
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
The a2 Milk Company Limited (ATM)
Date this disclosure made:27-Aug-2026
Date of last disclosure:
03-Dec-2025
Director or senior manager giving disclosure
Full name(s):Yohan Senaratne
Name of listed issuer:The a2 Milk Company Limited
Name of related body corporate (if applicable):N/A
Position held in listed issuer:Managing Director – International
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
(1) Unlisted performance rights (Performance
Rights) representing an entitlement to acquire fully
paid ordinary shares in ATM (Ordinary Shares).
(2) Ordinary Shares
Nature of the affected relevant interest(s):(1)(b) & (c) and (2) Spouse of registered holder
and beneficial owner.
(1)(a) Registered holder and beneficial owner.
For that relevant interest-
Number held in class before acquisition or disposal:(1) 341,192 Performance Rights of which:
(a) 148,650 are due to vest on a date to be
determined by the Board follow ing the release of
ATM’s full year audited results for FY2026
provided certain performance conditions are met;
(b) 120,159 are due to vest on a date to be
determined by the Board follow ing the release of
ATM’s full year audited results for FY2027
provided certain performance conditions are met;
and
(c) 72,383 are due to vest on a date to be
determined by the Board follow ing the release of
ATM’s full year audited results for FY2028
provided certain performance conditions are met
(2) 95,319 Ordinary Shares.
Number held in class after acquisition or disposal:(1) 192,542 Performance Rights of which:
(a) 120,159 are due to vest on a date to be
determined by the Board follow ing the release of
ATM’s full year audited results for FY2027
provided certain performance conditions are met;
and
(b) 72,383 are due to vest on a date to be
determined by the Board follow ing the release of
ATM’s full year audited results for FY2028
provided certain performance conditions are met.
(2) 243,969 Ordinary Shares.
Current registered holder(s):
(1)(a) Yohan Senaratne
(1)(b), (c) and (2) Aditi Kane
Registered holder(s) once transfers are registered:
(1)(a) and (b) Aditi Kane
(2) Aditi Kane who is the registered holder of
95,319 Ordinary Shares, and Yohan Senaratne
who is the registered holder of 148,650 Ordinary
Shares
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative: N/A
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:
1
Details of transactions requiring disclosure-
Date of transaction:
20-Aug-2026
Nature of transaction: Vesting and automatic exercise of 148,650
Performance Rights, resulting in the issue of
148,650 Ordinary Shares.
Name of any other party or parties to the transaction (if known):
a2 ESS Holdings Pty Limited as trustee for a2
Group Employee Share Trust (transferor of
Ordinary Shares)
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
Nil
Number of financial products to which the transaction related:
(1) 148,650 Performance Rights
(2) 148,650 Ordinary Shares
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
N/A
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
N/A
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
19 August 2026
---
Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity The a2 Milk Company Limited (Company)
ABN 97 769 415 292
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the
director for the purposes of section 205G of the Corporations Act.
Name of Director
David Landt Bortolussi
Date of last notice
2 March 2026
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be
disclosed in this part.
Direct or indirect interest
Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
DMZSK Super Pty Ltd (ACN 617 428 216),
as trustee for D & M Bortolussi
Superannuation Fund, holds 1,228,402
performance rights and 242,346 ordinary
shares.
DMZSK Pty Ltd (ACN 128 544 838), as
trustee for D&M Bortolussi Family Trust,
holds all other interests (both existing and
acquired).
Mr Bortolussi’s voting power in DMZSK
Super Fund Pty Ltd and DMZSK Pty Ltd is
above 20%.
Date of change
20 August 2026
No. of securities held prior to change
1. 1,553,008 Performance Rights.
2. 882,729 Fully Paid Ordinary Shares.
Class
1. Performance Rights.
2. Fully Paid Ordinary Shares.
Number acquired
1. nil Performance Rights.
2. 690,066 Fully Paid Ordinary Shares.
Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 01/01/2011
Number disposed
1. 690,066 Performance Rights.
2. nil Fully Paid Ordinary Shares.
Value/Consideration
Note: If consideration is non-cash, provide details and estimated valuation
Employee incentive
No. of securities held after change
1. 862,942 Performance Rights.
2. 1,572,795 Fully Paid Ordinary Shares.
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
Exercise of 690,066 performance rights
following their vesting.
Exercise satisfied by transfer of ordinary
shares issued to the Employee Share Scheme
Trust.
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be
disclosed in this part.
Detail of contract
N/A
Nature of interest
N/A
Name of registered holder
(if issued securities)
N/A
Date of change
N/A
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in relation
to which the interest has changed
N/A
Interest acquired
N/A
Interest disposed
N/A
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
N/A
Interest after change
N/A
Part 3 –
+
Closed period
Were the interests in the securities or contracts detailed
above traded during a
+
closed period where prior written
clearance was required?
N/A
If so, was prior written clearance provided to allow the
trade to proceed during this period?
N/A
Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
If prior written clearance was provided, on what date was
this provided?
N/A
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.